Table 1.

Characteristics of the Cohort by Pancreatic Cancer Stage at Diagnosis

Characteristic	All Patients		Locoregional Resectable		Locoregional Unresectable		Distant		P
	No.	%	No.	%	No.	%	No.	%
Total	15,037	–	2,078	14%	4,234	28%	8,725	58%
Age at diagnosis, y									<.0001
66–69	2,576	17%	464	22%	566	13%	1,546	18%
70–74	3,807	25%	629	30%	933	22%	2,245	26%
75–79	4,087	27%	594	29%	1,137	27%	2,356	27%
80–84	2,926	19%	309	15%	914	22%	1,703	20%
85+	1,641	11%	82	4%	684	16%	875	10%
Sex									<.0001
Male	6,820	45%	889	43%	1,804	43%	4,127	47%
Female	8,217	55%	1,189	57%	2,430	57%	4,598	53%
Race									<.0001
White	12,838	85%	1,875	90%	3,550	84%	7,413	85%
Black	1,437	10%	114	5%	438	10%	885	10%
Other	762	5%	89	4%	246	6%	427	5%
Census tract median income									<.0001
1st quartile	3,760	25%	403	19%	1,140	27%	2,217	25%
2nd quartile	3,769	25%	499	24%	1,074	25%	2,196	25%
3rd quartile	3,758	25%	541	26%	1,049	25%	2,168	25%
4th quartile	3,750	25%	635	31%	971	23%	2,144	25%
Urban-rural residence									<.05
Metro	12,990	86%	1,830	88%	3,625	86%	7,535	86%
Non-metro	2,047	14%	248	12%	609	14%	1,190	14%
Region									<.0001
Northeast	3,963	26%	614	30%	1,019	24%	2,330	27%
South	2,605	17%	379	18%	745	18%	1,481	17%
Midwest	2,195	15%	259	12%	620	15%	1,316	15%
West	6,274	42%	826	40%	1,850	44%	3,598	41%
Married									<.0001
Yes	8,137	54%	1,277	61%	2,143	51%	4,717	54%
No	6,421	43%	741	36%	1,945	46%	3,735	43%
Unknown	479	3%	60	3%	146	3%	273	3%
Charlson comorbidity score									<.0001
0	7,928	53%	1,184	57%	2,177	51%	4,567	52%
1	4,209	28%	597	29%	1,175	28%	2,437	28%
2+	2,900	19%	297	14%	882	21%	1,721	20%
Site									<.0001
Head	7,779	52%	1,558	75%	2,919	69%	3,302	38%
Body/tail	3,278	22%	280	13%	525	12%	2,473	28%
Duct/other	3,980	26%	240	12%	790	19%	2,950	34%